CD1D and neoplasm: Moreover, the CAR19‐iNKT cells were found to eradicate the lymphomas in the brain, and in combination with all‐trans retinoic acid, which enhanced CD1D expression on tumor cells, the cytotoxicity of CAR19‐iNKT cells was further enhanced.